Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II/III STUDY Of ACP-01 for angina pectoris

Trial Profile

Phase II/III STUDY Of ACP-01 for angina pectoris

Planning
Phase of Trial: Phase II/III

Latest Information Update: 17 Jan 2019

At a glance

  • Drugs ACP 01 (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2019 According to a Hemostemix media release, the company expects to file an IND application with the FDA in Q1 2019.
    • 20 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top